サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1375862

総合代謝パネル検査の市場規模、シェア、動向分析レポート：分析項目別、疾患別、最終用途別、地域別、セグメント別予測、2023年～2030年

Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report By Analytes (K+, Na+, Cl-, CO2, Glucose), By Disease, By End-use (Laboratory, PoC), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
総合代謝パネル検査の市場規模、シェア、動向分析レポート：分析項目別、疾患別、最終用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年10月04日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

総合代謝パネル検査市場の成長と動向：

Grand View Research社の最新レポートによると、世界の包括的代謝パネル検査市場規模は2030年までに208億7,000万米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 9.1％で拡大すると予測されます。世界の疾病負担の増加と新規診断製品の出現が市場を牽引

慢性疾患の有病率の上昇とヘルスケア支出を抑制する必要性の高まりは、疾患の早期診断と定期的なモニタリングの需要を増加させ、CMP検査市場を押し上げると予想されます。バイオチップ、マイクロアレイ、コンパニオン診断薬など、技術的に進歩した製品のイントロダクションが、異常の早期発見の必要性を後押ししています。CMP検査は、いくつかの疾患の同定、診断、モニタリングのために、14の分析物を評価する費用対効果と時間の節約になる方法を提供します。

ヘルスケアに関する消費者の意識の高まりは、CMP検査市場を牽引すると予想される主な要因の1つです。世界中の多くの組織が、疾患、利用可能な治療オプション、早期診断と予防措置の利点に関する認知度向上に取り組んでいます。例えば、国際糖尿病財団（International Diabetes Foundation）や米国糖尿病協会（American Diabetes Association）は、いくつかの啓発キャンペーンやその他の広告手段を通じて、糖尿病の診断とモニタリングの緊急の必要性を強調している主要な団体の一部です。

総合代謝パネル検査市場では、製品価格に微妙な違いがあるため、消費者の購買行動は中程度に複雑です。さまざまな市場プレーヤーが提供する製品は、競争企業間の敵対関係を高めるために戦略的に価格設定されています。市場の競争が激化するにつれて、安全性、有効性、感度、特異度といった診断法の改善に対する消費者のニーズはかつてないほど高まると予想されます。

ここ数年、医療診断の状況は、改良された診断製品の発売やバイオマーカーのイントロダクションよってパラダイムシフトが起きています。しかし、再発や疾患の進行は、特に高齢者において依然として高い水準にあります。強力なアンメットニーズは、CMP検査分野において画期的なファーストインクラス診断薬を開発する重要な機会となっています。

包括的代謝パネル検査市場レポート・ハイライト

  • 腎臓病セグメントは2022年に32.71%の最大売上シェアを占め、このセグメントは高い疾患有病率と分析物の最大利用率によって牽引されます。
  • 糖尿病セグメントは予測期間中にCAGR 9.9%の最速成長が見込まれます。糖尿病患者の50％近くが未診断のままであり、総合代謝パネル検査市場に有利な成長機会をもたらしています。
  • PoCセグメントは予測期間中、最も速いCAGR 9.8％で成長する見込みです。PoCによるCMP検査は、操作の容易さ、携帯性、結果の迅速さ、サンプルの必要性の低さなどが牽引しています。
  • 検査室セグメントは、2022年に59.97％と最も高い売上シェアを占めたが、これは入手の容易さ、市場への浸透度の高さ、使用量の増加、臨床的に重要な結果によるものです。
  • アジア太平洋地域は、ヘルスケアインフラの改善、慢性疾患にかかりやすい高齢者の増加、消費者意識の高まり、可処分所得の増加、全体的な経済発展に牽引され、予測期間中11.7%のCAGRで最も高い成長が見込まれています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 包括的な代謝パネル検査市場の変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 包括的な代謝パネル検査市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 総合代謝パネル検査市場：分析推定・動向分析

  • 総合代謝パネル検査市場：重要なポイント
  • 総合代謝パネル検査市場：動向と市場シェア分析、2022年および2030年
  • K+
  • な+
  • Cl-
  • CO2
  • グルコース
  • バン
  • クレアチニン
  • Ca++
  • アルブミン
  • 総タンパク質
  • ALP
  • オルタナティブ
  • AST
  • 総ビリルビン

第5章 総合代謝パネル検査市場：疾患の推定・動向分析

  • 総合代謝パネル検査市場：重要なポイント
  • 総合代謝パネル検査市場：動向と市場シェア分析、2022年および2030年
  • 腎臓病
  • 肝臓病
  • 糖尿病
  • その他

第6章 総合代謝パネル検査市場：最終用途の推定・動向分析

  • 総合代謝パネル検査市場：重要なポイント
  • 総合代謝パネル検査市場：動向と市場シェア分析、2022年および2030年
  • 研究室
  • 実証実験
  • PoC（機器）

第7章 総合代謝パネル検査市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別の包括的な代謝パネル検査市場：主要なマーケットプレースのポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Abbott
    • Quest Diagnostics
    • Laboratory Corporation of America Holdings
    • Sonic Healthcare Limited
    • Unipath
    • SYNLAB International GmbH
    • ARUP Laboratories
    • Genoptix Inc.
    • Nova Biomedical
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 3 North America comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 4 North America comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 7 U.S. comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 8 U.S. comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 10 Canada comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 11 Canada comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 13 Europe comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 14 Europe comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 17 Germany comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 18 Germany comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 20 UK comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 21 UK comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 23 France comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 24 France comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 26 Italy comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 27 Italy comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 29 Spain comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 30 Spain comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 32 Denmark comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 33 Denmark comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 35 Sweden comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 36 Sweden comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 38 Norway comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 39 Norway comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 45 Japan comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 46 Japan comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 48 China comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 49 China comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 51 India comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 52 India comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Australia comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 54 Australia comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 55 Australia comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Thailand comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 57 Thailand comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 58 Thailand comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 60 South Korea comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 61 South Korea comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 63 Latin America comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 64 Latin America comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 67 Brazil comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 68 Brazil comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 70 Mexico comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 71 Mexico comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 73 Argentina comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 74 Argentina comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 80 South Africa comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 81 South Africa comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 86 UAE comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 87 UAE comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 89 Kuwait comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 90 Kuwait comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Comprehensive metabolic panel testing: Market outlook
  • Fig. 8 Comprehensive metabolic panel testing: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Comprehensive metabolic panel testing market driver impact
  • Fig. 13 Comprehensive metabolic panel testing market restraint impact
  • Fig. 14 Comprehensive metabolic panel testing market strategic initiatives analysis
  • Fig. 15 Comprehensive metabolic panel testing market: Disease movement analysis
  • Fig. 16 Comprehensive metabolic panel testing market: Disease outlook and key takeaways
  • Fig. 17 Kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Liver diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Comprehensive metabolic panel testing market: Disease movement analysis
  • Fig. 22 Comprehensive metabolic panel testing market: Disease outlook and key takeaways
  • Fig. 23 K+ market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Na+ market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cl- market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 CO2 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Glucose market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 BUN market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Creatinine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Ca++ market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Albumin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Total protein market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 ALP market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 ALT market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 AST market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Total bilirubin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Comprehensive metabolic panel testing market: End-Use movement analysis
  • Fig. 38 Comprehensive metabolic panel testing market: End-Use outlook and key takeaways
  • Fig. 39 Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 PoC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 PoC (instruments) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Global comprehensive metabolic panel testing market: Regional movement analysis
  • Fig. 43 Global comprehensive metabolic panel testing market: Regional outlook and key takeaways
  • Fig. 44 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-3-68038-747-6

Comprehensive Metabolic Panel Testing Market Growth & Trends:

The global comprehensive metabolic panel testing market size is expected to reach USD 20.87 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 9.1% from 2023 to 2030. The market driven by an increasing global disease burden and the emergence of novel diagnostic products.

Rising prevalence of chronic diseases coupled with increasing need to curb healthcare expenditure are expected to boost the CMP testing market by increasing the demand for early disease diagnosis and regular monitoring. Introduction of technologically advanced products, such as biochips, microarrays, and companion diagnostics, has driven the necessity for early detection of anomalies. CMP testing offers a cost-effective and time-saving method for evaluating 14 analytes for identification, diagnosis, or monitoring of several diseases.

Rising consumer awareness regarding healthcare is one of the major factors anticipated to drive the market for CMP testing. Many organizations worldwide are working toward increasing awareness pertaining to diseases, available treatment options, and benefits of early diagnosis and precautions. For instance, the International Diabetes Foundation and the American Diabetes Association are some of the key organizations that emphasize the urgent need for diagnosing and monitoring diabetes through several awareness campaigns and other modes of advertisement.

The buying behavior of consumers is moderately complex in the comprehensive metabolic panel testing market, due to subtle differences in product prices. The products offered by various market players have been strategically priced to increase competitive rivalry. As the market becomes increasingly competitive, consumer needs are anticipated to reach at an all-time high for improved diagnostics - in terms of safety, efficacy, sensitivity, and specificity.

The medical diagnostics landscape has undergone a paradigm shift over the last few years, driven by the launch of improved diagnostic products and introduction of biomarkers. However, recurrence and disease progression remain high, especially among geriatric patients. Strong unmet needs present a key opportunity to develop breakthrough first-in-class diagnostics in the CMP testing space.

Comprehensive Metabolic Panel Testing Market Report Highlights:

  • The kidney diseases segment accounted for the largest revenue share of 32.71% in 2022, and the segment is driven by a high disease prevalence and maximum utilization of analytes.
  • The diabetes segment is expected to grow at the fastest CAGR of 9.9% during the forecast period. Nearly 50% of diabetics remain undiagnosed, presenting a lucrative opportunity for growth for the comprehensive metabolic panel testing market.
  • The PoC segment is expected to grow at the fastest CAGR of 9.8% over the forecast period. The PoC CMP tests are driven by their ease of operation, portability, speed of results, and lesser requirement of the sample.
  • The laboratories segment accounted for the highest revenue share of 59.97% in 2022, driven by easy availability, high market penetration, increased usage, and clinically significant results.
  • Asia Pacific is expected to grow at the highest CAGR of 11.7% over the forecast period, driven by improvements in healthcare infrastructure, a rise in the number of older people, who are more susceptible to chronic illnesses, growth in consumer awareness, a rise in disposable income, and overall economic development.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Analytes
    • 1.1.2. Disease
    • 1.1.3. End use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Analytes outlook
    • 2.2.2. Disease outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Comprehensive Metabolic Panel Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Comprehensive Metabolic Panel Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Comprehensive Metabolic Panel Testing Market: Analytes Estimates & Trend Analysis

  • 4.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
  • 4.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. K+
    • 4.3.1. K+ market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Na+
    • 4.4.1. Na+ market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Cl-
    • 4.5.1. Cl- market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. CO2
    • 4.6.1. CO2 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Glucose
    • 4.7.1. Glucose market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. BUN
    • 4.8.1. BUN market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Creatinine
    • 4.9.1. Creatinine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Ca++
    • 4.10.1. Ca++ market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. Albumin
    • 4.11.1. Albumin market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.12. Total Protein
    • 4.12.1. Total protein market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.13. ALP
    • 4.13.1. ALP market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.14. ALT
    • 4.14.1. ALT market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.15. AST
    • 4.15.1. AST market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.16. Total Bilirubin
    • 4.16.1. Total bilirubin market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Comprehensive Metabolic Panel Testing Market: Disease Estimates & Trend Analysis

  • 5.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
  • 5.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Kidney Diseases
    • 5.3.1. Kidney diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Liver Diseases
    • 5.4.1. Liver diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Diabetes
    • 5.5.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Comprehensive Metabolic Panel Testing Market: End-Use Estimates & Trend Analysis

  • 6.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
  • 6.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Laboratories
    • 6.3.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.2. Emergency departments
      • 6.3.2.1. Emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.3. Hospital wards
      • 6.3.3.1. Hospital wards market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.4. Primary care
      • 6.3.4.1. Primary care market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.5. Pharmacy
      • 6.3.5.1. Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.6. Telemedicine
      • 6.3.6.1. Telemedicine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. PoC
    • 6.4.1. PoC market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Emergency departments
      • 6.4.2.1. Emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.3. Hospital wards
      • 6.4.3.1. Hospital wards market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.4. Primary care
      • 6.4.4.1. Primary care market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.5. Pharmacy
      • 6.4.5.1. Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.6. Telemedicine
      • 6.4.6.1. Telemedicine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. PoC (Instruments)
    • 6.5.1. PoC market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.2. Piccolo Xpress
      • 6.5.2.1. Piccolo xpress market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.3. Skyla-HB1
      • 6.5.3.1. Skyla-HB1 market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.4. DRI-CHEM NX500
      • 6.5.4.1. DRI-CHEM NX500 market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.5. Others
      • 6.5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Comprehensive Metabolic Panel Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Comprehensive Metabolic Panel Testing Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Abbott
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Quest Diagnostics
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Laboratory Corporation of America Holdings
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Sonic Healthcare Limited
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Unipath
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. SYNLAB International GmbH
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. ARUP Laboratories
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Genoptix Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Nova Biomedical
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives